Delirium after deep brain stimulation for Parkinson's disease: a meta-analysis of incidence and risk factors
- PMID: 39843798
- DOI: 10.1007/s10143-025-03206-9
Delirium after deep brain stimulation for Parkinson's disease: a meta-analysis of incidence and risk factors
Abstract
Deep brain stimulation (DBS) is a valuable treatment for Parkinson's disease (PD), but postoperative delirium (POD) is a common complication. Understanding the risk factors for POD is crucial for optimizing patient selection and developing preventative measures. This systematic review and meta-analysis aims to identify predictors of POD in PD patients undergoing DBS surgery. We conducted a comprehensive search of four major databases for cohort studies on POD in patients undergoing DBS for PD, up to June 2024. Two reviewers independently screened studies, assessed the risk of bias using the Newcastle-Ottawa Scale, and extracted data. Meta-analysis was conducted using Review Manager, with heterogeneity assessed the I2 statistic and chi-square p value. Subgroup and sensitivity analyses were also performed to explore the consistency of findings. Eleven studies, including 1,368 patients, were analyzed to determine the incidence of POD in PD patients undergoing DBS. The incidence of POD in PD patients undergoing DBS, which was found to be 21% (95% CI: [14.6%, 27.4%]). Age, Mini-Mental State Examination (MMSE), and Non-Motor Symptom Scale (NMSS) were significant predictors, with effect sizes of (OR = 1.10, 95% CI: [1.06, 1.15], P < 0.00001), (OR = 0.85, 95% CI: [0.72, 1.00], P = 0.05), and (OR = 1.01, 95% CI: [1.00, 1.02], P = 0.04), respectively. However, gender, UPDRS-III ON score, brain atrophy, diabetes, Hamilton Anxiety Score (HAMA), operation time, disease duration, BMI, and cerebral infarction were not significant predictors. This meta-analysis suggests that age, cognitive function, and non-motor symptoms are important factors associated with POD patients undergoing DBS surgery. Further research with larger sample sizes and diverse populations is needed to confirm these findings and identify more specific predictors.
Keywords: Deep brain stimulation; Delirium; Parkinsonism; Parkinson’s disease.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Risk factors for delirium occurring after deep brain stimulation surgery in patients with Parkinson's disease.Acta Neurochir (Wien). 2024 Nov 23;166(1):474. doi: 10.1007/s00701-024-06330-5. Acta Neurochir (Wien). 2024. PMID: 39578305
-
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease.J Parkinsons Dis. 2025 Jun;15(4):879-891. doi: 10.1177/1877718X251334049. Epub 2025 May 20. J Parkinsons Dis. 2025. PMID: 40390641
-
Motor outcomes in unilateral, bilateral rapid, and bilateral delayed staging deep brain stimulation for Parkinson's disease.J Parkinsons Dis. 2024 Nov;14(8):1614-1622. doi: 10.1177/1877718X241296014. Epub 2024 Dec 8. J Parkinsons Dis. 2024. PMID: 39957194
-
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2. Cochrane Database Syst Rev. 2023. Update in: Cochrane Database Syst Rev. 2024 Apr 08;4:CD013856. doi: 10.1002/14651858.CD013856.pub3. PMID: 36602886 Free PMC article. Updated.
-
Non-pharmacological interventions for preventing delirium in hospitalised non-ICU patients.Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013307. doi: 10.1002/14651858.CD013307.pub2. Cochrane Database Syst Rev. 2021. PMID: 34280303 Free PMC article.
References
-
- Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW et al (2018) Prevalence of Parkinson’s disease across North America. Npj Park Dis 4:21. https://doi.org/10.1038/s41531-018-0058-0 - DOI
-
- Kleiner-Fisman G, Herzog J, Fisman DN, Tamma F, Lyons KE, Pahwa R et al (2006) Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes. Mov Disord 21:S290–304. https://doi.org/10.1002/mds.20962 - DOI - PubMed
-
- Charles PD, Gill CE, Davis TL, Konrad PE, Benabid A-L (2008) Is deep brain stimulation neuroprotective if applied early in the course of PD? Nat Clin Pract Neurol 4:424–426. https://doi.org/10.1038/ncpneuro0848 - DOI - PubMed
-
- Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR et al (2018) Apomorphine subcutaneous infusion in patients with Parkinson’s disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol 17:749–759. https://doi.org/10.1016/S1474-4422(18)30239-4 - DOI - PubMed
-
- Fox SH, Katzenschlager R, Lim S, Barton B, De Bie RMA, Seppi K et al (2018) International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson’s disease. Mov Disord 33:1248–1266. https://doi.org/10.1002/mds.27372 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous